(Q34062340)

30 July 2017

1 reference

title

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. (English)

1 reference

30 July 2017

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism (English)

0 references

0 references

0 references

1 reference

1 reference

venous thromboembolism

1 reference

van Der Heijden JF

1

1 reference

30 July 2017

B A Hutten

2

1 reference

30 July 2017

H R Büller

3

1 reference

30 July 2017

M H Prins

4

1 reference

30 July 2017

J F van der Heijden

1

0 references

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

2002

0 references

published in

1 reference

30 July 2017

CD002001

1 reference

30 July 2017

4

1 reference

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial.

30 July 2017

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Safety of treatment with oral anticoagulants in the elderly. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002001

10.1002/14651858.CD002001

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference